Pandox Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Los beneficios de Pandox han disminuido a una tasa media anual de -4.2%, mientras que en la industria Real Estate los beneficios crecieron en un 3.1% anualmente. Los ingresos han ido creciendo a una tasa media de 6.6% al año. La rentabilidad financiera de Pandox es de 0.2%, y sus márgenes netos son de 1.1%.

Información clave

-4.2%

Tasa de crecimiento de los beneficios

-6.8%

Tasa de crecimiento del BPA

Crecimiento de la industria Real Estate	11.6%
Tasa de crecimiento de los ingresos	6.6%
Rentabilidad financiera	0.2%
Margen neto	1.1%
Próxima actualización de resultados	12 Jul 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Industry Analysts Just Upgraded Their Pandox AB (publ) (STO:PNDX B) Revenue Forecasts By 16%

Oct 28

Is Pandox (STO:PNDX B) Using Too Much Debt?

Sep 26

We Think Pandox (STO:PNDX B) Is Taking Some Risk With Its Debt

May 30

Analysts Just Made A Stunning Upgrade To Their Pandox AB (publ) (STO:PNDX B) Forecasts

Feb 12

Pandox (STO:PNDX B) Has A Somewhat Strained Balance Sheet

Jan 15

Pandox (STO:PNDX B) Use Of Debt Could Be Considered Risky

Sep 18

Pandox (STO:PNDX B) May Have Issues Allocating Its Capital

Jun 27

Pandox (STO:PNDX B) Seems To Be Using A Lot Of Debt

May 31

Our Take On The Returns On Capital At Pandox (STO:PNDX B)

Mar 11

What Type Of Returns Would Pandox's(STO:PNDX B) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Feb 02

Based On Its ROE, Is Pandox AB (publ) (STO:PNDX B) A High Quality Stock?

Jan 12

Pandox (STO:PNDX B) Use Of Debt Could Be Considered Risky

Dec 22

Will Pandox (STO:PNDX B) Multiply In Value Going Forward?

Nov 30

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Pandox. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

OM:PNDX B Ingresos, gastos y beneficios (SEK Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Mar 24	6,997	78	203
31 Dec 23	6,849	-585	197
30 Sep 23	6,774	648	203
30 Jun 23	6,306	1,875	185
31 Mar 23	6,014	2,959	166
31 Dec 22	5,537	4,217	153
30 Sep 22	4,740	4,355	146
30 Jun 22	4,069	2,988	149
31 Mar 22	3,389	1,611	152
31 Dec 21	3,247	610	157
30 Sep 21	2,968	51	146
30 Jun 21	2,850	-368	156
31 Mar 21	2,821	-691	161
31 Dec 20	3,178	-1,399	171
30 Sep 20	3,946	198	174
30 Jun 20	4,598	543	173
31 Mar 20	5,453	1,632	179
31 Dec 19	5,553	2,706	175
30 Sep 19	5,473	2,185	174
30 Jun 19	5,363	2,776	168
31 Mar 19	5,263	2,777	157
31 Dec 18	5,124	2,820	148
30 Sep 18	4,848	3,232	141
30 Jun 18	4,559	2,945	137
31 Mar 18	4,326	3,068	130
31 Dec 17	4,269	3,140	124
30 Sep 17	4,247	2,719	122
30 Jun 17	4,235	2,761	119
31 Mar 17	4,112	2,349	121
31 Dec 16	3,945	2,201	117
30 Sep 16	3,769	2,115	113
30 Jun 16	3,661	1,951	110
31 Mar 16	3,658	2,131	97
31 Dec 15	3,529	2,131	94
30 Sep 15	3,432	1,575	93
30 Jun 15	3,281	1,390	90
31 Mar 15	3,112	1,276	88
31 Dec 14	3,076	1,253	82
31 Dec 13	2,897	948	64

Ingresos de calidad: PNDX B tiene un gran one-off loss de SEK861.0M impacto en sus últimos 12 meses de resultados financieros a 31st March, 2024.

Margen de beneficios creciente: Los actuales márgenes de beneficio(1.1%) de PNDX B son inferiores a los del año pasado (49.2%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de PNDX B han disminuido en un 4.2% al año en los últimos 5 años.

Acelerando crecimiento: PNDX B ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.

Beneficios vs. Industria: PNDX B tuvo un crecimiento negativo de los beneficios (-97.4%) durante el año pasado, lo que dificulta la comparación con la media de la industria Real Estate (-75.2%).

Pandox Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Información clave

Actualizaciones de resultados anteriores recientes

First quarter 2024 earnings released

Full year 2023 earnings: EPS misses analyst expectations

Pandox AB (publ) to Report Fiscal Year 2023 Results on Mar 08, 2024

Full year 2023 earnings: EPS misses analyst expectations

Pandox AB (publ) to Report Fiscal Year 2024 Results on Feb 06, 2025

Third quarter 2023 earnings released: EPS: kr2.48 (vs kr9.16 in 3Q 2022)

Recent updates

First quarter 2024 earnings released

An unknown buyer completed the acquisition of DoubleTree by Hilton Montreal from Pandox AB (publ) (OM:PNDX B).

Pandox AB (Publ) Approves Dividend

Upcoming dividend of kr4.00 per share

Pandox's (STO:PNDX B) Dividend Will Be Increased To SEK4.00

Full year 2023 earnings: EPS misses analyst expectations

Dividend increased to kr4.00

Pandox AB (publ) to Report Fiscal Year 2023 Results on Mar 08, 2024

Pandox AB (publ) Proposes a Dividend

Full year 2023 earnings: EPS misses analyst expectations

We Think Pandox (STO:PNDX B) Is Taking Some Risk With Its Debt

Pandox AB (publ) to Report Fiscal Year 2024 Results on Feb 06, 2025

Third quarter 2023 earnings released: EPS: kr2.48 (vs kr9.16 in 3Q 2022)

Pandox (STO:PNDX B) Takes On Some Risk With Its Use Of Debt

Pandox AB (publ), Annual General Meeting, Apr 10, 2024

Consensus EPS estimates fall by 13%

New minor risk - Profit margin trend

Second quarter 2023 earnings: Revenues exceed analyst expectations

Consensus EPS estimates fall by 31%

Does Pandox (STO:PNDX B) Have A Healthy Balance Sheet?

Price target decreased by 13% to kr143

Insider recently bought kr895k worth of stock

First quarter 2023 earnings: Revenues miss analyst expectations

Less than half of directors are independent

Upcoming dividend of kr2.50 per share at 2.0% yield

Key Executive recently bought kr536k worth of stock

With EPS Growth And More, Pandox (STO:PNDX B) Makes An Interesting Case

Insider recently bought kr429k worth of stock

Chief Commercial Officer recently bought kr282k worth of stock

Chief Executive Officer recently bought kr490k worth of stock

Consensus EPS estimates fall by 12%

Full year 2022 earnings: EPS and revenues miss analyst expectations

Pandox AB (publ) Proposes Dividend for 2022

An unknown buyer acquired InterContinental from Montreal Pandox AB (publ) (OM:PNDX B) for CAD 80 million.

Is Now An Opportune Moment To Examine Pandox AB (publ) (STO:PNDX B)?

Pandox AB (publ) to Report Fiscal Year 2022 Results on Mar 10, 2023

Second quarter 2022 earnings released: EPS: kr7.45 (vs kr0.038 loss in 2Q 2021)

Consensus EPS estimates increase by 44%

Industry Analysts Just Upgraded Their Pandox AB (publ) (STO:PNDX B) Revenue Forecasts By 16%

Pandox AB (publ) to Report Fiscal Year 2022 Results on Feb 10, 2023

Is Pandox (STO:PNDX B) Using Too Much Debt?

Pandox AB (publ) (OM:PNDX B) acquired Hotel in the UK from Starwood Capital Operations, LLC for £40 million.

Pandox AB (publ) Announces Nomination Committee for the AGM 2023

Pandox AB (publ) (OM:PNDX B) agreed to acquire NH Brussels Louise in central Brussels from NH Hotel Group, S.A. (BME:NHH).

Consensus forecasts updated

Investor sentiment improved over the past week

Price target increased to kr168

Second quarter 2022 earnings: Revenues exceed analyst expectations

Pandox AB (publ), Annual General Meeting, Apr 12, 2023

Pandox AB (Publ) Announces Executive Changes

We Think Pandox (STO:PNDX B) Is Taking Some Risk With Its Debt

Pandox AB (publ) to Report Fiscal Year 2023 Results on Feb 08, 2024

Director recently bought kr401k worth of stock

First quarter 2022 earnings: Revenues miss analyst expectations

Consensus EPS estimates fall by 28%

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Pandox AB (publ) to Report Fiscal Year 2021 Results on Mar 11, 2022

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Analysts Just Made A Stunning Upgrade To Their Pandox AB (publ) (STO:PNDX B) Forecasts

Consensus revenue estimates increase by 37%

Consensus EPS estimates fall by 20%

Pandox (STO:PNDX B) Has A Somewhat Strained Balance Sheet

Third quarter 2021 earnings released

Price target increased to kr158

Pandox (STO:PNDX B) Use Of Debt Could Be Considered Risky

Price target increased to kr153

Second quarter 2021 earnings released: kr0.04 loss per share (vs kr1.79 loss in 2Q 2020)

Pandox (STO:PNDX B) May Have Issues Allocating Its Capital

Pandox (STO:PNDX B) Seems To Be Using A Lot Of Debt

Desglose de ingresos y gastos
Beta